{
}
Regeneron Pharmaceuticals, Inc. has received a buy rating from UBS, highlighting its focus on developing treatments for eye diseases, inflammatory conditions, and cancer. The company's net sales are primarily derived from product sales (56.6%) and collaboration agreements (40.4%), with significant partnerships with Sanofi, Bayer, and Roche. As of the end of 2022, Regeneron boasts a clinical development portfolio of approximately 35 products.
Regeneron Pharmaceuticals, Inc. has received a buy rating from UBS, highlighting its focus on developing treatments for eye diseases, inflammatory conditions, and cancer. The company's net sales are primarily derived from product sales (56.6%) and collaboration agreements (40.4%), with significant partnerships with Sanofi, Bayer, and Roche. As of the end of 2022, Regeneron boasts a clinical development portfolio of approximately 35 products.
The global diabetic retinopathy devices market, valued at USD 12.47 billion in 2022, is projected to grow at a robust CAGR of around 30% through 2030, driven by rising diabetes cases and an aging population. Non-proliferative diabetic retinopathy is expected to dominate, while North America will lead regionally, with significant contributions from the APAC region due to its large diabetic population. Key players include F. Hoffmann-La Roche, Novartis, and Regeneron, focusing on innovative treatments and technologies.
Sanofi is investing 300 million euros for a 16% stake in a new joint venture with Orano Med to develop radiopharmaceuticals targeting rare cancers, particularly using the radioisotope lead-212. This partnership aims to leverage expertise in biopharma and nuclear technology to advance cancer treatment. The joint venture is valued at 1.9 billion euros, following Sanofi's recent licensing of an experimental drug for neuroendocrine tumors.
The global telemedicine market is projected to exceed USD 14 billion by 2030, driven by the rising demand for regular health check-ups and the active participation of key industry players in innovation and partnerships. North America is expected to lead the market, with telemonitoring services showing significant revenue growth. Notable companies like Teladoc Health and Rudolf Riester GmbH are advancing the sector with new solutions, including AI-supported telemedicine tools and mobile clinics for remote areas.
Bayer
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
regeneron pharmaceuticals receives buy rating as it expands drug portfolio
United States Dollar
Bayer AG
Sanofi
Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
DEU
FRA
USA
Roche
Bayer
Sanofi
Show more
16:08 01.11.2024
Regeneron Pharmaceuticals receives buy rating amid strong sales and collaborations
United States Dollar
Bayer AG
Sanofi
Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
DEU
FRA
USA
Roche
Bayer
Sanofi
Show more
16:08 01.11.2024
diabetic retinopathy market poised for significant growth driven by rising diabetes cases
Indian Rupee
Pakistani Rupee
Chinese Yuan
United States Dollar
Regeneron Pharmaceuticals, Inc.
Sanofi
Coherus BioSciences, Inc.
Novartis AG
Bayer AG
Kodiak Sciences Inc.
HANLIM PHARM.CO.LTD
Intas Pharmaceuticals Ltd.
SUN Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
PAK
CHN
IND
Bayer
Regeneron Pharmaceuticals
Sun Yat-Sen
Novartis
F. Hoffmann-La Roche
Show more
14:04 26.10.2024
Sanofi invests 300 million euros in joint venture for radiopharmaceuticals
Euro
Eli Lilly and Company
Orano Group
Bristol-Myers Squibb Company
Novartis AG
AstraZeneca PLC
Bayer AG
Sanofi
FRA
USA
Paul Hudson
Bayer
AstraZeneca
Eli Lilly
Novartis
Show more
13:20 17.10.2024
global telemedicine market projected to exceed 14 billion by 2030
United States Dollar
Indian Rupee
USARAD.CO
SHL Telemedicine
WELL Health Technologies Corp.
First Derm
DocOnline
SOC Telemed Inc.
Memd Columbia LLC
Practo.
iCliniq
Vesta Teleradiology
DirectDerm
Teladoc Health, Inc.
Doximity, Inc.
MediciNova, Inc.
Samsung Health U.S
American Well Corporation
Zenas BioPharma, Inc. Common Stock
Rudolf Riester GmbH
Array Behavioral Care.
Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd.
USA
Teladoc Health
Bayer
Joerns Healthcare
Hicuity Health
Rudolf Riester GmbH
Inc.
Show more
09:00 03.10.2024
Trending
Subcategory
Startups & Entrepreneurship
Corporate News
Industry Trends
Global Trade Developments
Government Economic Policies
Stock Market Updates
Retail and Consumer Goods
Industry Mergers & Acquisitions
Supply Chain Management
Global Financial Events
Venture Capital Investments
Private Equity Deals
Workplace Trends
Market Analysis and Predictions
Cryptocurrency & Blockchain Regulations
Funding Rounds & Investments
Finance Mergers & Acquisitions
Central Bank Actions
Energy Sector Developments
Inflation and Monetary Impact
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Samsung Securities Co.,Ltd.
Microsoft Corporation
Taiwan Semiconductor Manufacturing Company Limited
Verizon Communications Inc.
OpenAI ERC USD
The Goldman Sachs Group, Inc.
Dell Technologies Inc.
European Union Bonds
BRAINBEES SOLUTIONS LTD
Eternal Limited
CarTrade Tech Limited
PB Fintech Limited
OLA ELECTRIC MOBILITY LTD
KuCoin Token USD
CANVAS N Co.,Ltd.
Baidu, Inc.
iFLYTEK CO.,LTD
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
Japanese Yen
British Pound Sterling
Australian Dollar
New Zealand Dollar
Vietnamese Đồng
South Korean Won
Egyptian Pound
New Taiwan Dollar
Indonesian Rupiah
South African Rand
United Arab Emirates Dirham
Malaysian Ringgit
Singapore Dollar
Lebanese Pound
People:
Donald Trump
Howard Lutnick
Shigeru Ishiba
Scott Bessent
Jamieson Greer
Abdulaziz bin Salman Al Saud
Mohammad Al Tamimi
Mohammad Altamimi
Jensen Huang
Sam Altman
Xi Jinping
Chris Wright
Christopher Flinos
Mohammed bin Salman Al Saud
John Abraham
Swaminathan Aiyar
Todd Blanche
Justin Sun
Changpeng Zhao
Cameron Adams